But one Food and Drug Administration (FDA) indication at a time, that could start to change.
The heart disease indication means Medicare Part D plans can cover the drug.
In April, for instance, Eli Lilly announced study results demonstrating Zepbound significantlyimproved symptoms of obstructive sleep apnea.
Photo Illustration by Amelia Manley for Verywell Health; Getty Images
Why Doesnt Medicare Cover Obesity Medication?
Medicare Part D and Medigap plans are also unlikely to cover them.
The Obesity Action Coalition is lobbying Congress about the legislation.
Medicares coverage of AOMs at their current prices…would increase overall federal spending, CBO said.
That could result in higher premiumsthe monthly amount Medicare recipients pay for their plans.
A byproduct of those mechanisms of action is weight loss.
Almost three million Americans are living with undiagnosed diabetes, half of whom have overweight.
Its important to discuss with your healthcare provider whether this medication could be suitable for you.
More indications for GLP-1 drugs are on the horizon, which means more insurance coverage may be, too.
